Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
---|
03/31/2010 | EP1620091B1 Inhibitors of glutaminyl cyclase |
03/31/2010 | CN101687860A Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain |
03/30/2010 | US7687664 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it |
03/30/2010 | US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders; |
03/25/2010 | WO2010032437A1 Nitrogen-containing heterocyclic compound and pest control agent |
03/25/2010 | WO2010031735A1 Piperazine d3 and 5-ht2a receptor modulators |
03/25/2010 | WO2009055514A3 Fungicidal compounds and mixtures |
03/25/2010 | US20100076196 Process for the preparation of iloperidone |
03/25/2010 | US20100075974 Heterocyclic gpr40 modulators |
03/25/2010 | CA2737291A1 Nitrogen-containing heterocyclic compound and pest control agent |
03/24/2010 | EP1877390B1 Benzisoxazole piperazine compounds and methods of use thereof |
03/24/2010 | CN101679267A Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative |
03/24/2010 | CN101677552A Aminoazoline and urea derivatives for combating animal pests |
03/18/2010 | US20100069453 Certain Chemical Entities, Compositions, and Methods |
03/18/2010 | US20100069451 Salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7, 7a- octahydrobenzo[d]isoxazol-4-one |
03/18/2010 | US20100069450 Salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7, 7a- octahydrobenzo[d]isoxazol-4-one |
03/18/2010 | US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
03/17/2010 | EP2162439A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases |
03/17/2010 | CN101675035A Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments |
03/16/2010 | US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
03/16/2010 | CA2372575C Bradykinin receptor antagonists |
03/11/2010 | WO2010027051A1 Substituted acetophenone compound, process for producing same, and use of same |
03/11/2010 | WO2010026918A1 PROCESS FOR PRODUCTION OF α-TRIFLUOROMETHYL-β-SUBSTITUTED- β-AMINO ACID |
03/11/2010 | WO2010008734A3 Methods of Preparing Imidazole-Based Bicyclic Compounds |
03/10/2010 | CN101665469A Heterocyclic compounds useful as Nurrl activators |
03/09/2010 | US7674825 Cardiovascular disorders; stimulant of guanylate cyclase |
03/04/2010 | WO2010025035A1 Process for preparing isoxazole compounds |
03/04/2010 | WO2010023609A1 Oxazole, oxadiazole and thiazole derivatives as diacylglycerol acyltranferase inhibitors |
03/04/2010 | US20100056578 Insecticidal n-substituted sulfoximines |
03/04/2010 | US20100051928 Organic electroluminescence device |
03/03/2010 | EP2159216A1 Ih - Modulators |
03/03/2010 | EP2158188A2 Naphthalene isoxazoline invertebrate pest control agents |
03/03/2010 | EP1789401B1 Isoxazoline derivatives and their use as herbicides |
03/02/2010 | US7671092 Paclitaxel enhancer compounds |
03/02/2010 | US7670991 Substituted benzoylcyclohexenones and their use as herbicidal agents |
02/25/2010 | WO2010021882A2 Cold menthol receptor antagonists |
02/25/2010 | WO2010020521A1 Insceticidal compounds |
02/25/2010 | US20100048910 Process for preparing isoxazole compounds |
02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
02/25/2010 | US20100048652 Insecticidal compounds |
02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
02/25/2010 | CA2733160A1 Insecticidal compounds |
02/24/2010 | CN101657435A 5-oxo-isoxazoles as inhibitors of lipases and phospholipases |
02/23/2010 | US7666888 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity |
02/23/2010 | US7666866 Antithrombotic diamides |
02/23/2010 | US7666619 Compounds and methods for regulating bacterial growth and pathogenesis |
02/18/2010 | WO2010019547A1 Imine derivatives as cannabinoid receptor ligands |
02/18/2010 | WO2010019101A1 A crystalline form of 4- (5-{ (ir) -1- [5- (3- chlorophenyl) isoxazol-3-yl] ethoxy } - 4 -methyl- 4h- 1, 2,4- triazol-3-yl) pyridine |
02/18/2010 | WO2010019100A1 A new crystalline form of 4- (5- { (ir) -1- [5- (3- chlorophenyl) isoxazol-3-yl] ethoxy } -4-methyl-4h-l, 2, 4- triazol-3-yl) pyridine |
02/18/2010 | WO2010019098A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist |
02/18/2010 | WO2010019097A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient |
02/18/2010 | US20100041904 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives |
02/18/2010 | CA2733922A1 A crystalline form of 4-(5-{(1r)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
02/18/2010 | CA2733920A1 A new crystalline form of 4-(5-{(1r)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl)pyridine |
02/18/2010 | CA2733523A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a .beta.2-adrenoceptor agonist |
02/18/2010 | CA2733447A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient |
02/18/2010 | CA2731102A1 Imine derivatives as cannabinoid receptor ligands |
02/17/2010 | EP2152679A1 Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions |
02/17/2010 | EP1451163B1 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
02/17/2010 | CN101652354A insecticidal aryl isoxazoline derivatives |
02/17/2010 | CN101648919A 3-substituted salicylamide compound, preparation method, medicinal composition and application thereof |
02/16/2010 | US7663001 Preparation of isoxazolin-3-ylacylbenzene |
02/16/2010 | US7662972 Insecticidal and acaricidal activity for many agricultural insect pests, spider mites; endo- or ecto-parasiticide for mammals or birds; veterinary medicine; environmentally friendly |
02/16/2010 | US7662843 Isoxazoline compounds having MIF antagonist activity |
02/16/2010 | US7662771 Drug delivery; controlled/sustained release |
02/16/2010 | US7662750 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
02/16/2010 | CA2478183C Substituted amides |
02/16/2010 | CA2385081C Carboxylic acid compound and a medicament comprising it |
02/11/2010 | WO2010015613A1 Organic compounds |
02/11/2010 | US20100035948 Furanone compounds and lactam analogues thereof |
02/11/2010 | US20100035936 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands |
02/11/2010 | US20100035930 UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
02/11/2010 | CA2732932A1 Organic compounds |
02/10/2010 | EP2151437A1 Isoxazoline-substituted benzamide compound and pest control agent |
02/10/2010 | EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
02/10/2010 | EP1583748B1 Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and the highly pure crystals of zonisamide |
02/10/2010 | EP1525191B1 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
02/10/2010 | CN100588651C Process for production of (4,5-dihydroisoxazol-3-yl)thio- carboxamidine salts |
02/09/2010 | US7659307 Heterocyclic carboxamides and their use as fungicides |
02/09/2010 | CA2437505C Isoxazoline derivatives as anti-depressants |
02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
02/04/2010 | WO2010012795A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues |
02/04/2010 | WO2010012442A2 Insecticidal benzenedicarboxamide derivative |
02/04/2010 | US20100029949 Activator for Peroxisome Proliferator Activated Receptor |
02/04/2010 | US20100029588 Substituted phenylamidines and the use thereof as fungicides |
02/04/2010 | CA2731200A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues |
02/02/2010 | US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
01/28/2010 | WO2010009847A1 Heterocyclically substituted amides, method for the production thereof, and use as herbicides |
01/28/2010 | WO2009132452A8 Diaryl-cyclylalkyl derivatives as calcium channel blockers |
01/28/2010 | WO2009124962A3 Sulfonamides |
01/28/2010 | US20100022539 Isoxazole Compounds as Histamine H3 modulators |
01/28/2010 | US20100022530 Tetrahydrobenzoisoxazole and tetrahydroindazole derivatives as modulators of the mitotic motor protein |
01/27/2010 | EP2147919A1 Heterocyclic substituted amides, method for their manufacture and their use as herbicides |
01/27/2010 | EP2069020B1 Benzo[d]isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
01/27/2010 | EP1303503B1 Aniline derivatives |
01/26/2010 | US7652168 Synthesis of taxol enhancers |
01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |
01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |